The Current Ratio as of December 2025 (TTM) for Amplia Therapeutics Limited (INNMF) is 7.91

According to Amplia Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 7.91. This represents a change of 78.94% compared to the average of 4.42 of the last 4 quarters.

Amplia Therapeutics Limited (INNMF) Historical Current Ratio (quarterly & annually)

How has INNMF Current Ratio performed in the past?

The mean historical Current Ratio of Amplia Therapeutics Limited over the last ten years is 7.73. The current 7.91 Current Ratio has changed 10.12% with respect to the historical average. Over the past ten years (40 quarters), INNMF's Current Ratio was at its highest in in the June 2013 quarter at 43.94. The Current Ratio was at its lowest in in the December 2012 quarter at 0.

Amplia Therapeutics Limited (INNMF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Amplia Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amplia Therapeutics Limited (INNMF) Average Current Ratio

How has INNMF Current Ratio performed in the past?

The current Current Ratio of Amplia Therapeutics Limited (INNMF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Amplia Therapeutics Limited (INNMF) Current Ratio vs. Peers

How is INNMF’s Current Ratio compared to its peers?

Amplia Therapeutics Limited’s Current Ratio is greater than Relief Therapeutics Holding AG (4.05), greater than Oncotelic Therapeutics, Inc. (0.08), greater than Relief Therapeutics Holding AG (4.05), greater than PsyBio Therapeutics Corp. (0.13), greater than Helix BioPharma Corp. (0.42), greater than ZIVO Bioscience, Inc. (0.08), greater than Arch Biopartners Inc. (0.07), greater than Calliditas Therapeutics AB (publ) (3.13), greater than Cynata Therapeutics Limited (4.40), greater than Covalon Technologies Ltd. (6.57),

Build a custom stock screener for Amplia Therapeutics Limited (INNMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amplia Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amplia Therapeutics Limited (INNMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amplia Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.